Quick Answer
Emergent BioSolutions Inc. reported Total Assets of $1.39 billion for fiscal year 2024.
Emergent BioSolutions Inc. Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2024 | $1.39B | -23.8% |
| 2023 | $1.82B | -42.4% |
| 2022 | $3.17B | +7.0% |
| 2021 | $2.96B | +2.6% |
| 2020 | $2.88B | +23.9% |
| 2019 | $2.33B | +4.4% |
| 2018 | $2.23B | +108.3% |
| 2017 | $1.07B | +10.3% |
| 2016 | $970.11M | -6.5% |
| 2015 | $1.04B | +10.5% |
| 2014 | $938.69M | +49.8% |
| 2013 | $626.63M | +11.1% |
| 2012 | $564.23M | +3.2% |
| 2011 | $546.86M | +9.3% |
| 2010 | $500.32M | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $1.46B | -1.1% | +3.1% |
| June 30, 2025 | $1.42B | -6.4% | -0.6% |
| March 31, 2025 | $1.43B | -20.9% | +2.6% |
| December 31, 2024 | $1.39B | -23.8% | -6.0% |
| September 30, 2024 | $1.48B | -21.9% | -2.4% |
| June 30, 2024 | $1.51B | -30.5% | -16.1% |
| March 31, 2024 | $1.80B | -38.9% | -1.1% |
| December 31, 2023 | $1.82B | -42.4% | -3.7% |
- Emergent BioSolutions Inc. showed a decrease of -23.8% in Total Assets compared to the prior fiscal year.
- Over the 2010–2024 period, Emergent BioSolutions Inc.’s total assets has grown by 177.8% (from $500.32 million to $1.39 billion).
- The most recent figure is from Emergent BioSolutions Inc.’s fiscal year 2024 report (Form 10-K), filed with the SEC on March 4, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: